Cargando…
A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model
The CRISPR-based technology has revolutionized genome editing in recent years. This technique allows for gene knockout and evaluation of function in cell lines in a manner that is far easier and more accessible than anything previously available. Unfortunately, the ability to extend these studies to...
Autores principales: | Hu, Junhui, Schokrpur, Shiruyeh, Archang, Maani, Hermann, Kip, Sharrow, Allison C., Khanna, Prateek, Novak, Jesse, Signoretti, Sabina, Bhatt, Rupal S., Knudsen, Beatrice S., Xu, Hua, Wu, Lily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948229/ https://www.ncbi.nlm.nih.gov/pubmed/29766028 http://dx.doi.org/10.1016/j.omtm.2018.02.009 |
Ejemplares similares
-
CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
por: Schokrpur, Shiruyeh, et al.
Publicado: (2016) -
The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons
por: Minovitsky, Simon, et al.
Publicado: (2005) -
Combining VEGF receptor inhibitors and angiotensin-(1–7) to target renal cell carcinoma
por: Walther, Thomas, et al.
Publicado: (2021) -
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2016) -
MicroRNAs miR-146a/b negatively modulate the senescence-associated
inflammatory mediators IL-6 and IL-8
por: Bhaumik, Dipa, et al.
Publicado: (2009)